Antibody treatment against the extra-cellular domain of E-Cadherin inhibits proliferation of another breast cancer cell line (MCF-7) by redistributing YAP from the nucleus to the cytoplasm (Kim et al., 2011). Here, YAP1 is linked to breast carcinoma.